INmune Bio, Inc. (NASDAQ:INMB) Q2 2024 Earnings Call Transcript August 1, 2024
INmune Bio, Inc. beats earnings expectations. Reported EPS is $-0.5, expectations were $-0.63.
Operator: Greetings, and welcome to the INmune Bio Second Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the question-and-answer session. [Operator Instructions] As a reminder, this conference is being recorded. A...
